Showing results (41-50 of 2,467) with videos related to
Sort By:
Pageof 247
The Journal of Biological Chemistry|November 7, 2001
Cooperative coactivation of estrogen receptor alpha in ZR-75 human breast cancer cells by SNURF and TATA-binding proteinBradley Saville, Hetti Poukka, Mark Wormke, et al.Molecular Cancer Therapeutics|March 18, 2004
A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanesChunhua Qin, Derek Morrow, Jessica Stewart, et al.Molecular Cancer Therapeutics|July 4, 2012
Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clustersKyounghyun Kim, Gayathri Chadalapaka, Satya S Pathi, et al.International Journal of Cancer|July 8, 2009
Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cellsSudhakar Chintharlapalli, Sabitha Papineni, Maen Abdelrahim, et al.Methods in Molecular Biology (Clifton, N.J.)|October 31, 2017
An Endothelial Cell/Mesenchymal Stem Cell Coculture Cord Formation Assay to Model Vascular Biology In VitroMichelle Swearingen, Beverly Falcon, Sudhakar Chintharlapalli, et al.Cancer Research|March 5, 2009
Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolismIsmael Samudio, Michael Fiegl, Michael AndreeffCancer Research|March 8, 2013
Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapyDamien Gerald, Sudhakar Chintharlapalli, Hellmut G Augustin, et al.Pharmacology & Therapeutics|June 12, 2016
Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agentsBeverly L Falcon, Sudhakar Chintharlapalli, Mark T Uhlik, et al.Pageof 247